SAT524 Relaxin: A Novel Marker for Pro-Tumoral Thyroid Cancer Microenvironment?

Disclosure: A. Kotwal: None. R.G. Bennett: None. B. Swanson: None. W. Goldner: None. A. Yuil-Valdes: None. N. Whiteman: None. O. Shats: None. Background: Differentiated thyroid cancer (DTC) generally has a favorable prognosis, however, 30% have recurrence and progression hence there is a critical ne...

Descripción completa

Detalles Bibliográficos
Autores principales: Kotwal, Anupam, Bennett, Robert G, Swanson, Benjamin, Goldner, Whitney, Yuil-Valdes, Ana, Whiteman, Nicholas, Shats, Oleg
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Thyroid
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10553651/
http://dx.doi.org/10.1210/jendso/bvad114.1996

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10553651/
http://dx.doi.org/10.1210/jendso/bvad114.1996

Ejemplares similares